Skip to main content

ORIGINAL RESEARCH article

Front. Oncol., 20 July 2020
Sec. Gastrointestinal Cancers
This article is part of the Research Topic Novel Molecular Targets and Treatments for Gastroesophageal Cancer View all 26 articles

RETRACTED: RBFOX3 Promotes Gastric Cancer Growth and Progression by Activating HTERT Signaling

Retracted
\nChen Luo,,&#x;Chen Luo1,2,3Xiaojian Zhu,,&#x;Xiaojian Zhu1,2,3Qilin LuoQilin Luo1Fanqin Bu,,Fanqin Bu1,2,3Chao Huang,,Chao Huang1,2,3Jingfeng Zhu,,Jingfeng Zhu1,2,3Jiefeng Zhao,,Jiefeng Zhao1,2,3Wenjun Zhang,,Wenjun Zhang1,2,3Kang Lin,,Kang Lin1,2,3Cegui Hu,Cegui Hu2,3Zeng Zong,Zeng Zong1,3Hongliang Luo,Hongliang Luo1,3Jun HuangJun Huang1Zhengming Zhu
Zhengming Zhu1*
  • 1Department of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China
  • 2Department of Clinical Medical, Jiangxi Medical College of Nanchang University, Nanchang, China
  • 3Jiangxi Province Key Laboratory of Molecular Medicine, Nanchang, China

Citation: Luo C, Zhu X, Luo Q, Bu F, Huang C, Zhu J, Zhao J, Zhang W, Lin K, Hu C, Zong Z, Luo H, Huang J and Zhu Z (2020) RBFOX3 Promotes Gastric Cancer Growth and Progression by Activating HTERT Signaling. Front. Oncol. 10:1044. doi: 10.3389/fonc.2020.01044

Received: 13 April 2020; Accepted: 26 May 2020;
Published: 20 July 2020; Retracted: 31 August 2021.

Edited by:

Wen Wen Xu, Jinan University, China

Reviewed by:

Yoshinori Katakura, Kyushu University, Japan
Yang Liu, China Medical University, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.